- Motley Fool•5 hours ago
This dynamic duo appears to be on track to give Gilead's portfolio of hepatitis C products a run for its money.
- Market Realist•23 hours ago
Procter & Gamble rose 1.2% to close at $89.46 per share on September 28. The stock’s weekly, monthly, and YTD price movements were 1.9%, 1.3%, and 15.5%.
Johnson & Johnson Chairman and CEO Alex Gorsky speaks with WSJ’s Laura Landro about healthcare regulation, drug innovation and other topics, at a recent Wall Street Journal Viewpoints breakfast in New ...
Johnson & Johnson (JNJ)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||117.81 x 400|
|Ask||118.13 x 400|
|Day's Range||117.39 - 118.62|
|52wk Range||91.84 - 126.07|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||22.01|
|Avg Vol (3m)||6,318,931|
|Dividend & Yield||3.20 (2.68%)|